SLT – Mechanism of Action

Description:

Brian Francis, MD – from the University of Southern California of Los Angeles and the Doheny Eye Institute was one of the early adopters of the  Selective Laser Trabeculoplasty (SLT) technology – a micro-incisional glaucoma surgical procedure.

Publish Date:

January 29, 2017

Speaker:

Brian Francis, MD

Ophthalmology
Devices

Learn more about our innovative Vision solutions

Digital Duet Device

Digital Duet

The first and only all-in-one digital platform for Glaucoma and PCO therapies
Digital Trio Device

Digital Trio

3 in 1 digital platform for Glaucoma and Retina care
Optilight Device

OptiLight

A bright solution for dry eyes
Array LaserLink Device

ArrayTM LaserLinkTM

Pattern Scanning Laser Technology
Vision One Device

Vision One

Modular Multi-Wave Photocoagulator
Selecta Duet Device

Selecta Duet

SLT Technology and a Yag Photodisruptor in One Platform
Selecta Trio Device

Selecta Trio

Retinal, Cataract and Glaucoma Therapy in One Platform
Novus Spectra Device

Novus SpectraTM

High-Powered Photocoagulator
LumeProbe

LumeProbeTM

Endo-Photocoagulation Laser Probes

Explore Other Resources

Dry EyePeriorbital Muscle StimulationPress PublicationsPress ReleasesTreatment TypeVision Resource Hub
Dry EyePeriorbital Muscle StimulationPress PublicationsPress ReleasesTreatment TypeVision Resource Hub

Behind OptiLIFT’s Lid Laxity Innovation

READ MORE

    PB-1005974 rev B